Novavax COVID-19 vaccine approved for 12 to 17s by MHRA
News story The Medicines and Healthcare products Regulatory Agency has concluded that Nuvaxovid is safe and effective in this age group Nuvaxovid, the COVID-19 vaccine developed by Novavax, has today been granted an extension to its existing… read more